ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
27.44
+0.89 (3.35%)
At close: Dec 5, 2025, 4:00 PM EST
27.60
+0.16 (0.58%)
After-hours: Dec 5, 2025, 7:59 PM EST

ACADIA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4,6423,0535,1402,5783,7528,499
Upgrade
Market Cap Growth
63.83%-40.60%99.40%-31.29%-55.85%28.98%
Upgrade
Enterprise Value
3,8502,5374,8522,2043,2787,904
Upgrade
Last Close Price
27.4418.3531.3115.9223.3453.46
Upgrade
PE Ratio
17.8013.48----
Upgrade
Forward PE
41.4435.9027.40---
Upgrade
PS Ratio
4.393.197.084.987.7519.24
Upgrade
PB Ratio
5.064.1711.916.446.9413.56
Upgrade
P/TBV Ratio
5.764.9814.046.446.9413.58
Upgrade
P/FCF Ratio
23.4719.42308.70---
Upgrade
P/OCF Ratio
23.3319.36307.78---
Upgrade
EV/Sales Ratio
3.682.656.684.266.7717.89
Upgrade
EV/EBITDA Ratio
35.5025.33----
Upgrade
EV/EBIT Ratio
40.7830.11----
Upgrade
EV/FCF Ratio
19.4616.14291.36---
Upgrade
Debt / Equity Ratio
0.060.070.130.160.120.08
Upgrade
Debt / EBITDA Ratio
0.450.47----
Upgrade
Debt / FCF Ratio
0.280.333.44---
Upgrade
Asset Turnover
0.910.991.090.800.650.56
Upgrade
Inventory Turnover
9.5313.3318.5351.2229.4435.81
Upgrade
Quick Ratio
2.772.182.133.826.106.44
Upgrade
Current Ratio
3.022.382.424.046.436.77
Upgrade
Return on Equity (ROE)
34.95%38.89%-14.73%-45.89%-28.75%-42.47%
Upgrade
Return on Assets (ROA)
5.11%5.44%-6.86%-21.70%-14.37%-18.66%
Upgrade
Return on Capital (ROIC)
7.38%8.27%-9.64%-26.18%-16.62%-21.09%
Upgrade
Return on Capital Employed (ROCE)
9.70%10.60%-14.80%-48.40%-28.20%-34.60%
Upgrade
Earnings Yield
5.63%7.42%-1.19%-8.38%-4.47%-3.31%
Upgrade
FCF Yield
4.26%5.15%0.32%-4.42%-3.38%-1.69%
Upgrade
Buyback Yield / Dilution
-1.70%-1.55%-1.32%-0.74%-2.01%-6.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.